Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinopathy develops at similar glucose levels but higher HbA<sub>1c</sub> levels in people with black African ancestry compared to white European ancestry: evidence for the need to individualize HbA<sub>1c</sub> interpretation.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Impact of mismatches in HbA<sub>1c</sub> vs glucose values on the diagnostic classification of diabetes and prediabetes.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Racial differences in performance of HbA<sub>1c</sub> for the classification of diabetes and prediabetes among US adults of non-Hispanic black and white race.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Circulating progenitor cells in patients with familial hypercholesterolemia.

Journal of clinical apheresis·2017
Same author

Glucose challenge test screening for prediabetes and early diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry.

Heart Asia·2016

Related Experiment Video

Updated: Jul 5, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Cardiometabolic risk: a Framingham perspective.

P W F Wilson1, J B Meigs

  • 1EPICORE, Emory University School of Medicine, Atlanta, GA, USA. peter.wf.wilson@emory.edu

International Journal of Obesity (2005)
|May 28, 2008
PubMed
Summary

Metabolic risk factors like adiposity and insulin resistance are key drivers of cardiovascular disease and type 2 diabetes. Identifying these factors aids in predicting and preventing these serious health conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Adiposity and metabolic risk factors are increasingly recognized as significant contributors to vascular disease and diabetes.
  • Understanding the interplay between these factors is crucial for effective disease prevention and management.

Purpose of the Study:

  • To review existing data on the association between adiposity, metabolic risk factors, and outcomes related to vascular disease and type 2 diabetes mellitus.
  • To identify common cardiometabolic risk factor clusters and their impact on disease development.

Main Methods:

  • A community cohort study utilizing both cross-sectional and prospective data.
  • Analysis included traditional cardiovascular disease and type 2 diabetes risk factors, alongside measures of insulin resistance, left ventricular hypertrophy, and vascular calcification.

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: Jul 5, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

  • Study population comprised middle-aged Caucasian adults.
  • Main Results:

    • A core cluster of cardiometabolic risk factors, including adiposity (BMI, waist circumference), abnormal lipids (HDL, triglycerides), and glucose/insulin metabolism, was identified.
    • Increased insulin resistance correlated with coronary artery calcification and left ventricular hypertrophy in women.
    • A higher burden of metabolic syndrome risk factors was significantly associated with increased risk for both cardiovascular disease and type 2 diabetes mellitus.

    Conclusions:

    • Cardiometabolic factors and insulin resistance are critical determinants in the pathogenesis of type 2 diabetes mellitus.
    • These factors also play a significant role in the development of both subclinical and clinical cardiovascular disease.